Infliximab rescue therapy in acute severe ulcerative colitis: more does not equal better
- PMID: 39236737
- DOI: 10.1016/S2468-1253(24)00229-2
Infliximab rescue therapy in acute severe ulcerative colitis: more does not equal better
Conflict of interest statement
VA has received grants from the Indian Council of Medical Research Center for Advanced Research and Excellence in Intestinal Diseases (grant number 55/4/11/CARE-ID/2018-NCD). SK declares no competing interests.
Comment on
-
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial.Lancet Gastroenterol Hepatol. 2024 Nov;9(11):981-996. doi: 10.1016/S2468-1253(24)00200-0. Epub 2024 Sep 2. Lancet Gastroenterol Hepatol. 2024. PMID: 39236736 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical